Full Press Release Details
dupixent dupilumab approved in japan for children aged 6 to 11 years with bronchial asthma.
REGN
dupixent dupilumab approved in japan for children aged 6 to 11 years with bronchial asthma
Key Takeaway: dupixent dupilumab approved in japan for children aged 6 to 11 years with bronchial asthma